Biorestorative Therapies (BRTX)
(Delayed Data from NSDQ)
$1.36 USD
+0.05 (3.82%)
Updated May 14, 2024 04:00 PM ET
After-Market: $1.35 -0.01 (-0.74%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *AMC5/14/24 |
---|---|
Current Quarter | -0.51 |
EPS Last Quarter | -0.57 |
Last EPS Surprise | 12.31% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.96 |
Next Year | -1.52 |
EPS (TTM) | -3.51 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.03M | 0.03M | 0.12M | 0.12M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.03M | 0.03M | 0.12M | 0.12M |
Low Estimate | 0.03M | 0.03M | 0.12M | 0.12M |
Year ago Sales | 0.03M | 0.07M | 0.15M | 0.12M |
Year over Year Growth Est. | 0.00% | -57.14% | -17.80% | 0.00% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.51 | -0.46 | -1.96 | -1.52 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.51 | -0.46 | -1.96 | -1.52 |
High Estimate | -0.51 | -0.46 | -1.96 | -1.52 |
Low Estimate | -0.51 | -0.46 | -1.96 | -1.52 |
Year ago EPS | -1.53 | -0.77 | -3.42 | -1.96 |
Year over Year Growth Est. | 66.67% | 40.26% | 42.69% | 22.45% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.51 | -0.46 | -1.96 | -1.52 |
7 Days Ago | -0.51 | -0.46 | -1.96 | -1.52 |
30 Days Ago | -0.51 | -0.46 | -1.96 | -1.52 |
60 Days Ago | -0.52 | -0.48 | -2.12 | -1.75 |
90 Days Ago | -0.52 | -0.48 | -2.12 | -1.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.51 | -0.46 | -1.96 | -1.52 |
Zacks Consensus Estimate | -0.51 | -0.46 | -1.96 | -1.52 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.57 | -0.64 | -0.77 | -1.53 | NA |
Estimate | -0.65 | -0.68 | -1.56 | -1.26 | NA |
Difference | 0.08 | 0.04 | 0.79 | -0.27 | 0.16 |
Surprise | 12.31% | 5.88% | 50.64% | -21.43% | 11.85% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more